Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and Validation of the lncRNA MYOSLID as a Regulating Factor of Necroptosis and Immune Cell Infiltration in Colorectal Cancer following Necroptosis-Related LncRNA Model Establishment. | Cancers (Basel) | 2022 | 36139524 | PubTator, text mining | PubMed |
| Cigarette Smoke and Morphine Promote Treg Plasticity to Th17 via Enhancing Trained Immunity. | Cells | 2022 | 36139385 | PubTator, text mining | PubMed |
| Co-Stimulatory Receptor Signaling in CAR-T Cells. | Biomolecules | 2022 | 36139142 | PubTator, text mining | PubMed |
| Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy. | J Oncol | 2022 | 36131793 | PubTator, text mining | PubMed |
| APRIL Drives a Coordinated but Diverse Response as a Foundation for Plasma Cell Longevity. | J Immunol | 2022 | 36130130 | PubTator, text mining | PubMed |
| CAR-T cell potency: from structural elements to vector backbone components. | Biomark Res | 2022 | 36123710 | PubTator, text mining | PubMed |
| High-throughput sequencing unravels the cell heterogeneity of cerebrospinal fluid in the bacterial meningitis of children. | Front Immunol | 2022 | 36119025 | PubTator, text mining | PubMed |
Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis. | Front Genet | 2022 | 36118856 | PubTator, text mining | PubMed |
| Advanced Nasopharyngeal Carcinoma: Current and Emerging Treatment Options. | Cancer Manag Res | 2022 | 36117730 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma. | BMC Med Genomics | 2022 | 36117156 | PubTator, text mining | PubMed |
| Sharks Provide Evidence for a Highly Complex TNFSF Repertoire in the Jawed Vertebrate Ancestor. | J Immunol | 2022 | 36113883 | PubTator, text mining | PubMed |
| The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma. | Front Immunol | 2022 | 36110851 | PubTator, text mining | PubMed |
| O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer. | Pathol Oncol Res | 2022 | 36110252 | PubTator, text mining | PubMed |
| Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs. | Front Genet | 2022 | 36110218 | PubTator, text mining | PubMed |
| Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis. | Nat Commun | 2022 | 36097003 | PubTator, text mining | PubMed |
| Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma. | Front Genet | 2022 | 36092903 | PubTator, text mining | PubMed |
| Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer. | Front Genet | 2022 | 36092873 | PubTator, text mining | PubMed |
| Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma. | Front Cell Dev Biol | 2022 | 36092724 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma. | J Gastrointest Oncol | 2022 | 36092347 | PubTator, text mining | PubMed |
| Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements. | Front Immunol | 2022 | 36091031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=40